Meningococcal conjugate vaccination

Details for Australian Patent Application No. 2005237289 (hide)

Owner Novartis Vaccines and Diagnostics S.r.l.

Inventors Marshall, Cameron

Agent FB Rice

Pub. Number AU-B-2005237289

PCT Pub. Number WO2005/105140

Priority 0409750.7 30.04.04 GB; 0500787.7 14.01.05 GB

Filing date 29 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 4 August 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105140 Priority application(s): WO2005/105140

24 July 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics S.r.l.

4 August 2011 Application Accepted

  Published as AU-B-2005237289

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237290-Compositions for progeny gender control

2005237287-Epitopes related to coeliac disease